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SUMMARY
Objective: To identify measles virus genotypes in three cases of travelers suspected of 
measles infection. Methods: Samples (blood and urine) were collected for serology, virus 
isolation, and genotyping. Sera were analyzed for IgM antibodies against measles virus 
and rubella virus by enzyme-linked immunosorbent assay (ELISA) (Siemens – Marburg, 
Germany). Clinical samples (lymphocytes and urine) were inoculated into Statens Se-
rum Institute rabbit corneal epithelial cell line- ATCC CL 60 (SIRC) and Vero Slam cells. 
RNA was extracted from clinical samples and cell culture was inoculated and processed 
by polymerase chain reaction (PCR) with oligonucleotides specific for measles virus 
(MV) and rubella virus (RV). Results: All patients showed IgM negative serology for MV 
and positive IgM for RV. RV belonging to genotypes 1B, 1C, and 1E were isolated from 
patients who came from Finland, Peru, and Germany, respectively. Genotype 1B has 
been found in Europe and on the East Coast of South America; 1C has been found in 
Peru and the West Coast of South America, and 1E, first identified in 1997, now appears 
to have worldwide distribution. Conclusion: Information about RV and MV genotypes 
circulating in São Paulo is essential for the control of measles, rubella, and congenital 
rubella syndrome (CRS) in Brazil. 
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RESUMO
Análise molecular do vírus da rubéola em turistas suspeitos de 
infecção por sarampo em São Paulo, Brasil
Objetivo: Identificar o genótipo do vírus do sarampo em três viajantes suspeitos de in-
fecção por sarampo. Métodos: Amostras (sangue e urina) foram coletadas para soro-
logia, isolamento viral e genotipagem. As sorologias para pesquisa de IgM para o vírus 
do sarampo e da rubéola foi realizada utilizando-se o kit de ELISA (Siemens – Mar-
burg, Alemanha). As amostras clínicas (linfócito e urina) foram inoculadas na SIRC 
(Statens Serum Institute rabbit corneal epithelial cell line-ATCC CL 60) e nas células 
Vero Slam. O RNA foi extraído das amostras clínicas e das células inoculadas e proces-
sadas por PCR, utilizando oligonucleotideos específicos para sarampo e rubéola. Resul-
tados: Todos os pacientes apresentaram sorologia IgM negativa para sarampo e positivo 
para rubéola. Os vírus da rubéola isolados dos pacientes que vieram da Finlândia, Peru e 
Alemanha pertencem aos genótipos 1B, 1C e 1E, respectivamente. O genótipo 1B foi en-
contrado na Europa e na costa oriental da América do Sul, o genótipo 1C foi encontrado 
no Peru e na costa oeste da América do Sul e o genótipo 1E, identificado pela primeira 
vez em 1997, agora aparenta ser um genótipo com distribuição mundial. Conclusão: O 
conhecimento dos genótipos de sarampo e rubéola que circulam em São Paulo é essen-
cial para o controle do sarampo, rubéola e síndrome da rubéola congênita. 
Unitermos: Sarampo; rubéola; importado; genótipo.
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INTRODUCTION
Measles is one of the most highly transmissible human 
diseases. In Brazil the goal was to interrupt the transmis-
sion of endemic measles virus (MV) by the end of 2000 
using strategies recommended by the Pan American 
Health Organization (PAHO), which included vaccina-
tion activities, intended to achieve high population im-
munity, together with sensitive surveillance for suspected 
measles cases, incorporating effective virological and se-
rological surveillance1. Until measles is eradicated glob-
ally, the Americas face the risk of importation and sec-
ondary cases2. Across the world, migratory movements 
and travels to areas with low vaccine coverage have com-
promised eradication programs. 
São Paulo is the largest state in Brazil, with a popu-
lation of 37 million inhabitants. From 2001 to 2006, no 
indigenous measles cases were reported and only three 
imported cases, two from Japan in 2001 and 2002 (geno-
type D5) and one from another Asian country in 2005 
(genotype D5), were registered in São Paulo3,4. Molecular 
characterization of rubella virus (RV) and MV isolates 
has been successfully used to determine epidemiological 
links between cases and the geographic origin of import-
ed viruses. During the period of 2005-2006, three indi-
viduals who had recently arrived from Finland, Peru, 
and Germany, respectively, were suspected of measles 
due to rash and fever, and were reported to the health 
service quarantine staff. The results showed that these 
patients were infected with RV. Rubella is a common 
cause of childhood rash and fever, whose public health 
importance relates to the teratogenic effects of prima-
ry rubella infection in pregnant women. In 2003, the 
PAHO adopted a resolution calling for the elimination 
of rubella and congenital rubella syndrome (CRS) in the 
Americas by the year 20105. Three cases of imported ru-
bella diagnosed at the Adolfo Lutz Institute, São Paulo, 
Brazil are described.  
METHODS
PATIENTS AND SAMPLES
The first case was a 29-year-old male, unvaccinated, liv-
ing in São Paulo, who had previously traveled to Finland 
to work on September 30th, 2005. He returned ten days 
later and developed fever (39°C), sore throat, coryza, 
cough, and rash after three days. 
The second case was a 31-year-old woman, not preg-
nant, of unknown immunization status, living in Peru, 
who had come to São Paulo on October 3th, 2005. After 
one day, she developed fever (38°C), sore throat, coryza, 
cough, and rash.
The third case was a 28-year-old, male, Brazilian, un-
vaccinated, living in Germany, who had come to São Paulo, 
Brazil with his wife and two children on May 27th, 2006. 
After two days, he developed fever (39°C) and head-
ache, and after three days, conjunctivitis and rash. None 
of the individuals mentioned had been in contact with 
visitors from Brazil with rubella-like illness in the pre-
ceding days. 
Samples (blood and urine) were collected for serol-
ogy, virus isolation, and genome detection. Peripheral 
blood was separated with Ficoll-Hypaque gradients and 
suspended in Dulbecco’s Minimum Eagle Essential Me-
dium (DMEM, Invitrogen Life Technologies – Carlsbad, 
CA, USA) supplemented with 2% fetal bovine serum 
(FBV). The urine was collected in a sterile vessel and neu-
tralized with sodium bicarbonate to produce pH 7.0 as 
measured with indicator paper. 
SEROLOGY 
Serum rubella IgM antibody was determined with a com-
mercial Enzygnost anti-rubella virus IgM (Siemens — 
Marburg, Germany) according to the instructions pro-
vided by the manufacturer.
ISOLATION AD CELL CULTURE
The Statens Serum Institute rabbit corneal epithelial 
cell line- ATCC CL 60 (SIRC) and Vero Slam cell lines 
containing 1 x 106 cells/mL were grown in T25 flasks in 
DMEM/RPMI supplemented with 10% inactive fetal calf 
serum (FCS, Invitrogen Life Technologies – Carlsbad, 
CA, USA), 20 mM L-glutamine. The confluent cells were 
inoculated with 500 μL of each sample for one hour at 
room temperature. After one hour, each cell line received 
5mL of medium with 2% FCS and was incubated at 37°C. 
Cell cultures were observed for CPE daily during seven 
days as previously described6. The cells inoculated were 
harvested by centrifugation and RNA was extracted from 
the cell pellet. The growth of the virus in cultures of SIRC 
and Vero Slam cells was detected by a reverse transcrip-
tion-polymerase chain reaction (RT-PCR)7,8.
Uninfected and infected cultures were also prepared 
and were treated identically to the inoculated cells.
RNA EXTRACTION AND REVERSE TRANSCRIPTION
Nucleic acid extraction from 200 μL from samples and 
inoculated cell culture were extracted using TRI reagent 
(Molecular Research Center — Cincinnati, Ohio, USA). 
RV and MV-RNA were detected by the previously de-
scribed RT-PCR7,8. Both cDNA synthesis and PCR fol-
lowed a strict procedural condition to prevent con-
tamination, including redundant negative controls and 
segregated environments for pre- and post-amplification 
procedures. After PCR amplification, the presence of a 
product was confirmed by agarose gel electrophoresis 
and ethidium bromide staining.
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GENETIC CHARACTERIZATION
A 800-nt fragment of the E1 coding region containing 
the 739-nt World Health Organization (WHO) recom-
mended sequence window (nts 8731-9469) was amplified 
from cells inoculated using SuperScript II One-Step RT-
PCR (Invitrogen Life Technologies - Carlsbad, CA, USA). 
An aliquot of the 5 μL reverse transcription reaction was 
added to the PCR mix containing 10x Buffer (Invitrogen 
LifeTechnologies — Carlsbad, CA, USA), 2.5mM MgCl2, 
1.25mM each dNTPs, and Platinum Taq DNA polymerase 
(Invitrogen Life Technologies — Carlsbad, CA, USA). 
The forward and reverse primer of the first reaction and 
nested reaction were previously described9. The reaction 
cycle parameters were 94°C for 1 min, 50°C for 1 min, 
and 72°C for 2 min, for 30 cycles. After amplification, 
5 μL of the first round reaction mix was transferred to a 
new tube for the nested reaction, similar to that used in 
PCR amplifications. Amplification products were analyzed 
in a 1.5% agarose gel stained with ethidium bromide, us-
ing 1xTAE as the electrophoresis running buffer. Ampli-
fied DNA fragments were purified with PureLink PCR Pu-
rification Kit (Invitrogen Life Technologies — Carlsbad, 
CA, USA) and submitted to the sequencing reactions with 
ABI Prism Big Dye Terminator v3.1 Cycle Sequencing Kits 
(Applied Biosystems — Foster City, CA, USA) according 
to the manufacturer's protocol. Sequences obtained were 
analyzed by CLUSTAL X and BioEdit version 7.0 DNA 
analysis software, and were compared with the sequences 
of the WHO’s reference strains. Phylogenetic trees were 
constructed using the Lasergene (DNAstar, Inc.) software 
package. Three sequences obtained during this study are 
available under GenBank accession numbers: EU220248, 
EU220249, EU220250. 
RESULTS
All subjects were unvaccinated and present negative IgM 
serology for MV and positive IgM for RV. In addition, all 
three cases were serologically negative for parvovirus B19 
and human herpesvirus 6. The Vero Slam and SIRC cells 
inoculated were examined by phase-contrast microscopy 
during seven days. Vero Slam cells did not show cytopathic 
effects, but SIRC cells revealed an increased cellular refrac-
tivity. The first morphological changes were observed 24 
hours after the inoculation of RV, and they spread to com-
plete infection by the seventh day. The manifestations of the 
infection by RV were vacuolization of the cytoplasm at the 
cell poles and the contraction of the cytoplasm around the 
altered nucleus (cytophatic effect) (Figure 1). The samples 
and cells infected were processed by PCR for RV and MV. 
All samples and cells inoculated were negative for MV and 
positive for RV. The viral genome amplified was visualized 
in 2% agarose stained with ethidium bromide, and had 
an expected length of 185 base pairs, in agreement with 
the results obtained by Bosma et al7. A phylogenetic tree 
presenting the results of this study is shown in Figure 2. 
Every sequence obtained from isolates was compared with 
the reference strains recommended by the WHO, and used 
to construct a phylogenetic tree. Comparison of the nucle-
otide sequence of the E1 gene of three RV strains from São 
Paulo determined in this study identified three genotypes: 
1B, 1C, and 1E.
Figure 1 – ATCC CL 60 (SIRC) cells infected during seven 
days with urine sample from case no. 1. The cytophatic 
effect is characterized by a formation of foci consisting of 
small, circular cells (100x).
DISCUSSION
Since measles was declared eliminated from Brazil in 2000, 
this elimination status has been maintained through high 
measles-mumps-rubella (MMR) vaccination coverage, 
and most measles cases have been associated with im-
portation3,4. Brazil receives more than five million visitors 
from various countries every year, and over one million 
Brazilians travel abroad every year. Recently, four cases of 
measles virus were confirmed in São Paulo. Among these 
patients, one had recently traveled internationally, and the 
virus isolated belonged to genotype D4 with a genetic se-
quence closely related to those of viruses circulating in Eu-
rope10. This strain has been present in Europe for over 27 
months and led to more than 25,000 cases in 12 countries, 
suggesting that the genotype D4 may have been imported 
from Europe2. To the best of the authors’ knowledge, these 
cases are the first published reports of rubella disease in 
travelers returning to Brazil.
In Brazil, the state of São Paulo was the first to intro-
duce the MMR vaccine for routine childhood immuni-
zation in 1992, preceded by a catch-up campaign among 
children aged between one and 11 years10. To reduce rubel-
la transmission and prevent additional cases of CRS, Bra-
zil began a nationwide campaign to vaccinate women of 
childbearing age against rubella in 200010. After vaccina-
tion, cases of CRS and congenital rubella infection (CRI) 
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decreased, but in 2007, an epidemic of rubella occurred 
throughout Brazil. The most affected group was unvacci-
nated males between 20 and 29 years of age. Factors that 
contributed to the outbreak included the large number of 
unvaccinated young adults who had arrived to São Paulo 
from various cities of Brazil11. In 2008, Brazil launched a 
campaign for national rubella vaccination of all men and 
women between 20 and 39 years of age in order to accel-
erate the elimination of the disease, and approximately 
eight million men and women from that age group were 
vaccinated, a 96.75% coverage12. The rubella elimination 
strategy using the MMR vaccine has substantially helped 
to establish measles elimination, due to the vaccination of 
the adolescent and adult populations. 
In accordance with the established procedures of the 
regional measles laboratory network, composed of public 
health laboratories throughout the State of São Paulo, lab-
oratory evaluation of suspected cases and contacts includ-
ed serologic testing, viral culture, detection of viral RNA 
by RT-PCR, and viral genotyping1,5. The infectious causes 
of morbilliform rash and fever are varied and include MV, 
RV, human herpes virus type 6 (HHV6) and parvovirus 
B19, which clinically may resemble measles. For this rea-
son, the present patient was firstly misdiagnosed with 
measles, and only later the correct diagnosis was estab-
lished. Laboratory investigation is, therefore, a critical pre-
requisite for an accurate diagnosis to determine the cause 
of morbilliform rash. For example, in the country of Geor-
gia, in 2004, an outbreak of RV coincided with a measles 
flare-up outbreak; during this combined outbreak, 53% of 
suspected cases were IgM positive for MV and 12% tested 
positive for IgM to RV2. 
Figure 2 – Genetic relationship among the three rubella virus (RV) isolates (in bold) in comparison to reference viruses 
(WHO, 2007) and sequences obtained from GenBank. The phylogenetic tree was constructed using the Clustal W method 
of the MegAlign program (DNAStar x.0 software). Reference strains and sequences from GenBank are indicated with the 
accession number followed by strain name. 
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To monitor progress toward elimination, the PAHO 
recommends that all countries in the region have inte-
grated surveillance for measles and rubella. Genotypes of 
wild-type RV have been recognized by sequencing a stan-
dardized window of 739 nucleotides (nt) within the E1 
gene5. The characterization of genotypes during the final 
stages of rubella elimination is important for determining 
whether new rubella isolates represent endemic transmis-
sions or importations. 
Sequence analysis of rubella RNA amplified by 
RT-PCR identified three distinct rubella strains: 1B, 1C, 
and 1E, from the patients who came from Finland, Peru, 
and Germany, respectively. Genotype 1B has been found 
in Europe and on the East Coast of South America, 1C 
has been found in Peru and the West Coast of South 
America, and 1E, first identified in 1997, now appears to 
have worldwide distribution5.
 Data previously reported by the authors showed that 
genotype 1a was present in São Paulo as early as two years 
before the peak of the outbreak in 2000, and persisted 
until 200713. Recently, genotype 1a was found in Japan, 
Cambodia, and Kazakhstan14. The other two strains iso-
lated in 2000 and 2002 in São Paulo belonged to genotype 
1B and 1G, also described in Rio de Janeiro and Acre. 
Therefore, viruses of genotypes 1G and 1B were consid-
ered endemic in Brazil14-16. 
Molecular epidemiology has proved to be an essential 
tool to document the circulation and transmission of en-
demic RVs by characterizing each chain of transmission 
during the elimination phase, or representative samples 
from each outbreak during the control phase of integrated 
surveillance. Strengthening laboratory surveillance and 
immunization strategies will serve to improve awareness 
and detection of rubella and lead to the elimination of ru-
bella and CRS in the Americas. 
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